452 related articles for article (PubMed ID: 34737551)
1. An Overview on the Potential Roles of EGCG in the Treatment of COVID-19 Infection.
Bimonte S; Forte CA; Cuomo M; Esposito G; Cascella M; Cuomo A
Drug Des Devel Ther; 2021; 15():4447-4454. PubMed ID: 34737551
[TBL] [Abstract][Full Text] [Related]
2. The green tea catechin epigallocatechin gallate inhibits SARS-CoV-2 infection.
Henss L; Auste A; Schürmann C; Schmidt C; von Rhein C; Mühlebach MD; Schnierle BS
J Gen Virol; 2021 Apr; 102(4):. PubMed ID: 33830908
[TBL] [Abstract][Full Text] [Related]
3. Antiviral activity of green tea and black tea polyphenols in prophylaxis and treatment of COVID-19: A review.
Mhatre S; Srivastava T; Naik S; Patravale V
Phytomedicine; 2021 May; 85():153286. PubMed ID: 32741697
[TBL] [Abstract][Full Text] [Related]
4. Antiviral Effects of Green Tea EGCG and Its Potential Application against COVID-19.
Wang YQ; Li QS; Zheng XQ; Lu JL; Liang YR
Molecules; 2021 Jun; 26(13):. PubMed ID: 34209485
[TBL] [Abstract][Full Text] [Related]
5. EGCG, a Green Tea Catechin, as a Potential Therapeutic Agent for Symptomatic and Asymptomatic SARS-CoV-2 Infection.
Chourasia M; Koppula PR; Battu A; Ouseph MM; Singh AK
Molecules; 2021 Feb; 26(5):. PubMed ID: 33668085
[TBL] [Abstract][Full Text] [Related]
6. Epigallocatechin Gallate (EGCG), a Green Tea Polyphenol, Reduces Coronavirus Replication in a Mouse Model.
Park R; Jang M; Park YI; Park Y; Jung W; Park J; Park J
Viruses; 2021 Dec; 13(12):. PubMed ID: 34960802
[TBL] [Abstract][Full Text] [Related]
7. The green tea catechin EGCG provides proof-of-concept for a pan-coronavirus attachment inhibitor.
LeBlanc EV; Colpitts CC
Sci Rep; 2022 Jul; 12(1):12899. PubMed ID: 35902713
[TBL] [Abstract][Full Text] [Related]
8. Epigallocatechin-3-gallate, an active ingredient of Traditional Chinese Medicines, inhibits the 3CLpro activity of SARS-CoV-2.
Du A; Zheng R; Disoma C; Li S; Chen Z; Li S; Liu P; Zhou Y; Shen Y; Liu S; Zhang Y; Dong Z; Yang Q; Alsaadawe M; Razzaq A; Peng Y; Chen X; Hu L; Peng J; Zhang Q; Jiang T; Mo L; Li S; Xia Z
Int J Biol Macromol; 2021 Apr; 176():1-12. PubMed ID: 33548314
[TBL] [Abstract][Full Text] [Related]
9. A molecular docking study of EGCG and theaflavin digallate with the druggable targets of SARS-CoV-2.
Mhatre S; Naik S; Patravale V
Comput Biol Med; 2021 Feb; 129():104137. PubMed ID: 33302163
[TBL] [Abstract][Full Text] [Related]
10. Anti-SARS-CoV-2 activity of various PET-bottled Japanese green teas and tea compounds in vitro.
Ngwe Tun MM; Luvai E; Nwe KM; Toume K; Mizukami S; Hirayama K; Komatsu K; Morita K
Arch Virol; 2022 Jul; 167(7):1547-1557. PubMed ID: 35606466
[TBL] [Abstract][Full Text] [Related]
11. Significant Inactivation of SARS-CoV-2 In Vitro by a Green Tea Catechin, a Catechin-Derivative, and Black Tea Galloylated Theaflavins.
Ohgitani E; Shin-Ya M; Ichitani M; Kobayashi M; Takihara T; Kawamoto M; Kinugasa H; Mazda O
Molecules; 2021 Jun; 26(12):. PubMed ID: 34208050
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic potential of green tea catechin, (-)-epigallocatechin-3-
Dinda B; Dinda S; Dinda M
Phytomed Plus; 2023 Feb; 3(1):100402. PubMed ID: 36597465
[TBL] [Abstract][Full Text] [Related]
13. Antiviral Effects and Mechanisms of Green Tea Catechins on Influenza: A Perception on Combating Symptoms from COVID-19.
Man GCW; Zheng X; Hung SW; Chan LKY; Zhang T; Chen X; Chu KO; Huen ICY; Lui DWY; Wong AD; Wang CC
Curr Top Med Chem; 2024; 24(1):60-73. PubMed ID: 38291871
[TBL] [Abstract][Full Text] [Related]
14. Protective Effect of Epigallocatechin-3-Gallate (EGCG) in Diseases with Uncontrolled Immune Activation: Could Such a Scenario Be Helpful to Counteract COVID-19?
Menegazzi M; Campagnari R; Bertoldi M; Crupi R; Di Paola R; Cuzzocrea S
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708322
[TBL] [Abstract][Full Text] [Related]
15. The green tea catechin, epigallocatechin gallate inhibits chikungunya virus infection.
Weber C; Sliva K; von Rhein C; Kümmerer BM; Schnierle BS
Antiviral Res; 2015 Jan; 113():1-3. PubMed ID: 25446334
[TBL] [Abstract][Full Text] [Related]
16. Epigallocatechin-3-Gallate (EGCG) Inhibits SARS-CoV-2 Infection in Primate Epithelial Cells: (A Short Communication).
Hurst BL; Dickinson D; Hsu S
Microbiol Infect Dis; 2021; 5(2):. PubMed ID: 35291211
[TBL] [Abstract][Full Text] [Related]
17. Epigallocatechin gallate (EGCG) attenuates severe acute respiratory coronavirus disease 2 (SARS-CoV-2) infection by blocking the interaction of SARS-CoV-2 spike protein receptor-binding domain to human angiotensin-converting enzyme 2.
Ohishi T; Hishiki T; Baig MS; Rajpoot S; Saqib U; Takasaki T; Hara Y
PLoS One; 2022; 17(7):e0271112. PubMed ID: 35830431
[TBL] [Abstract][Full Text] [Related]
18. EGCG as an anti-SARS-CoV-2 agent: Preventive versus therapeutic potential against original and mutant virus.
Tsvetkov V; Varizhuk A; Kozlovskaya L; Shtro A; Lebedeva O; Komissarov A; Vedekhina T; Manuvera V; Zubkova O; Eremeev A; Shustova E; Pozmogova G; Lioznov D; Ishmukhametov A; Lazarev V; Lagarkova M
Biochimie; 2021 Dec; 191():27-32. PubMed ID: 34389380
[TBL] [Abstract][Full Text] [Related]
19. Multiple antiviral approaches of (-)-epigallocatechin-3-gallate (EGCG) against porcine reproductive and respiratory syndrome virus infection in vitro.
Ge M; Xiao Y; Chen H; Luo F; Du G; Zeng F
Antiviral Res; 2018 Oct; 158():52-62. PubMed ID: 30048655
[TBL] [Abstract][Full Text] [Related]
20. Epigallocatechin Gallate Inhibits the Uridylate-Specific Endoribonuclease Nsp15 and Efficiently Neutralizes the SARS-CoV-2 Strain.
Hong S; Seo SH; Woo SJ; Kwon Y; Song M; Ha NC
J Agric Food Chem; 2021 Jun; 69(21):5948-5954. PubMed ID: 34015930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
